Search

Your search keyword '"MacGregor, E A"' showing total 500 results
Start Over Author "MacGregor, E A"
500 results on '"MacGregor, E A"'

2. Transgender and Migraine

Author

MacGregor, E. Anne, van den Brink, Antoinette Maassen, Martelletti, Paolo, Series Editor, Maassen van den Brink, Antoinette, editor, and MacGregor, E. Anne, editor

Published
2019
Full Text
View/download PDF

12. Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2.

Author

MacGregor, E. Anne, Okonkwo, Rose, Detke, Holland C., Polavieja, Pepa, Fernandes, Maria S., and Pavlovic, Jelena M.

Subjects
*MIGRAINE prevention, *THERAPEUTIC use of monoclonal antibodies, *STATISTICS, *ONE-way analysis of variance, *MENSTRUATION, *TREATMENT effectiveness, *DESCRIPTIVE statistics, *QUALITY of life, *RESEARCH funding, *QUESTIONNAIRES, *DATA analysis, *HEADACHE
Abstract

Background: We evaluated galcanezumab for migraine prevention in patients who met International Classification of Headache Disorders, 3rd edition criteria for menstrually related migraine (MRM). Methods: Patients were identified post hoc from three double‐blind, randomized, phase 3 clinical trials in patients with episodic migraine. Patients completed a 1‐month prospective baseline period and up to 6 months (EVOLVE‐1 and ‐2, studies pooled) of double‐blind treatment with galcanezumab (120 mg/month) or placebo. Menses and headache information were recorded by electronic daily diary. Patients with a migraine attack starting during the 5‐day perimenstrual interval (first day of bleeding ± 2 days) for ≥2 of their first three diary‐recorded menstrual cycles were categorized as having MRM. The primary efficacy measure was mean change in monthly migraine headache days from baseline, averaged over Months 4 through 6. Response rates, change in monthly perimenstrual migraine headache days, monthly non‐perimenstrual migraine headache days, and quality of life were also assessed. Results: Post hoc MRM analysis criteria were met by 462/1133 women (41%). Mean (standard deviation) baseline monthly migraine headache days were 9.7 (±3.1; n = 146) for galcanezumab‐treated patients and 9.6 (±2.8; n = 316) for placebo‐treated patients. The mean change (standard error [SE]) in migraine headache days over Months 4 through 6 was −5.1 days (±0.39) for galcanezumab versus −3.2 (±0.35) for placebo (p < 0.001). The mean change (SE) in perimenstrual migraine headache days over Months 4 through 6 was −0.75 days (±0.08) for galcanezumab versus −0.49 (±0.07) for placebo (p = 0.004). For migraine headache days outside the perimenstrual period, the mean change in migraine headache days was −4.6 (±0.38) for galcanezumab and −2.8 (±0.33) for placebo (p < 0.001). Improvements in response rates and the Migraine‐Specific Quality of Life Questionnaire were also observed over Months 4 through 6. Conclusion: Galcanezumab was effective for migraine prevention in women with MRM. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Author

Sacco, Simona, Merki-Feld, Gabriele S., Ægidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Kurth, Tobias, Lampl, Christian, Lidegaard, Øjvind, Anne MacGregor, E., MaassenVanDenBrink, Antoinette, Mitsikostas, Dimos-Dimitrios, Nappi, Rossella Elena, Ntaios, George, Sandset, Per Morten, Martelletti, Paolo, and on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Published
2018
Full Text
View/download PDF

24. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

Author

Sacco, Simona, Merki-Feld, Gabriele S., Ægidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Gantenbein, Andreas R., Kurth, Tobias, Lampl, Christian, Lidegaard, Øjvind, Anne MacGregor, E., MaassenVanDenBrink, Antoinette, Mitsikostas, Dimos-Dimitrios, Nappi, Rossella Elena, Ntaios, George, Paemeleire, Koen, Sandset, Per Morten, Terwindt, Gisela Marie, Vetvik, Kjersti Grøtta, Martelletti, Paolo, and on behalf of the European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH)

Published
2018
Full Text
View/download PDF

26. The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility

Author

Steiner, T. J., Buse, D. C., Al Jumah, M., Westergaard, M. L., Jensen, R. H., Reed, M. L., Prilipko, L., Mennini, F. S., Láinez, M. J. A., Ravishankar, K., Sakai, F., Yu, S.-Y., Fontebasso, M., Al Khathami, A., MacGregor, E. A., Antonaci, F., Tassorelli, C., Lipton, R. B., and on behalf of Lifting The Burden: The Global Campaign against Headache

Published
2018
Full Text
View/download PDF

29. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Author

Sacco, Simona, Merki-Feld, Gabriele S., Ægidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Kurth, Tobias, Lampl, Christian, Lidegaard, Øjvind, Anne MacGregor, E., MaassenVanDenBrink, Antoinette, Mitsikostas, Dimos-Dimitrios, Nappi, Rossella Elena, Ntaios, George, Sandset, Per Morten, Martelletti, Paolo, and on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Published
2017
Full Text
View/download PDF

31. sj-pdf-1-cep-10.1177_03331024221118929 - Supplemental material for Efficacy of lasmiditan for the acute treatment of perimenstrual migraine

Author

MacGregor, E Anne, Komori, Mika, Krege, John Henry, Baygani, Simin, Vincent, Maurice, Pavlovic, Jelena, and Igarashi, Hisaka

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 110306 Endocrinology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases, Neuroscience
Abstract

Supplemental material, sj-pdf-1-cep-10.1177_03331024221118929 for Efficacy of lasmiditan for the acute treatment of perimenstrual migraine by E Anne MacGregor, Mika Komori, John Henry Krege, Simin Baygani, Maurice Vincent, Jelena Pavlovic and Hisaka Igarashi in Cephalalgia

Published
2022
Full Text
View/download PDF

32. sj-pdf-2-cep-10.1177_03331024221118929 - Supplemental material for Efficacy of lasmiditan for the acute treatment of perimenstrual migraine

Author

MacGregor, E Anne, Komori, Mika, Krege, John Henry, Baygani, Simin, Vincent, Maurice, Pavlovic, Jelena, and Igarashi, Hisaka

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 110306 Endocrinology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases, Neuroscience
Abstract

Supplemental material, sj-pdf-2-cep-10.1177_03331024221118929 for Efficacy of lasmiditan for the acute treatment of perimenstrual migraine by E Anne MacGregor, Mika Komori, John Henry Krege, Simin Baygani, Maurice Vincent, Jelena Pavlovic and Hisaka Igarashi in Cephalalgia

Published
2022
Full Text
View/download PDF

50. Repeats and refrains

Author

MacGregor, E., Finney, J., Philpott, C., and Spruce, G.

Subjects
History
Abstract

Traditional Western forms, including ritornello form, ternary form, rondo form, and theme and variations, all capitalise on the use of one primary theme which recurs throughout the piece, either in alternation with other themes or with variation on its own original material. In Hindustani classical music, the dhrupad uses a four-stanza form in which the opening theme returns in the closing stanza to create an arch-like structure. Recent examples of pieces which use recurring refrains to achieve a balance between musical repetition and contrast can be found from traditions all over the world. The head initially occurs in the synthesiser after the saxophone introduction. Identify where it recurs throughout the piece. It is notable that, in the Western classical tradition, the prevalence of structures carefully balancing musical repetition and contrast greatly reduced during the rise of modernism. For serialists, repetition and the generation of expectation was something to be avoided at all costs.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results